Financhill
Buy
62

GRC Quote, Financials, Valuation and Earnings

Last price:
$37.03
Seasonality move :
4.19%
Day range:
$37.12 - $37.93
52-week range:
$30.47 - $43.79
Dividend yield:
1.94%
P/E ratio:
24.61x
P/S ratio:
1.50x
P/B ratio:
2.64x
Volume:
55.6K
Avg. volume:
62.9K
1-year change:
1.81%
Market cap:
$987.5M
Revenue:
$659.7M
EPS (TTM):
$1.53

Earnings Data

Next earnings date for GRC
Apr 25
2025
Most recent earnings per share
$0.42
Missed by $0.03
(Feb 7/2025)
Consensus Estimate
$0.45
(Feb 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GRC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/25/2025 Q1 $164.8M -- -- $0.44 --
02/07/2025 Q4 $162.8M $162.7M $0.42 $0.45 -$0.03
10/25/2024 Q3 $172.5M $168.2M $0.49 $0.55 -$0.06
07/26/2024 Q2 $176.2M $169.5M $0.32 $0.44 -$0.12
04/25/2024 Q1 $168.5M $159.3M $0.30 $0.35 -$0.05
02/02/2024 Q4 $156.8M $160.6M $0.34 $0.25 $0.09
10/27/2023 Q3 -- -- $0.34 $0.33 $0.01
07/28/2023 Q2 -- -- $0.40 $0.27 $0.13
04/27/2023 Q1 -- -- $0.25 $0.20 $0.05
02/03/2023 Q4 -- -- $0.09 $0.18 -$0.09
10/28/2022 Q3 -- -- $0.09 $0.36 -$0.27
07/29/2022 Q2 -- -- -$0.04 $0.32 -$0.36
04/27/2022 Q1 -- -- $0.29 $0.34 -$0.05
02/04/2022 Q4 -- -- $0.25 $0.33 -$0.08
10/29/2021 Q3 -- -- $0.34 $0.34 --
07/23/2021 Q2 -- -- $0.27 $0.29 -$0.02
04/22/2021 Q1 -- -- $0.28 $0.28 --
02/05/2021 Q4 -- -- $0.26 $0.30 -$0.04
10/23/2020 Q3 -- -- $0.28 $0.28 --
07/24/2020 Q2 -- -- $0.22 $0.19 $0.03
04/23/2020 Q1 -- -- $0.21 $0.34 -$0.13
02/07/2020 Q4 -- -- $0.32 $0.34 -$0.02
10/25/2019 Q3 -- -- $0.37 $0.35 $0.02
07/26/2019 Q2 -- -- $0.40 $0.37 $0.03
04/25/2019 Q1 -- -- $0.28 $0.38 -$0.10
02/08/2019 Q4 -- -- $0.36 $0.39 -$0.03
10/26/2018 Q3 -- -- $0.41 $0.36 $0.05
07/27/2018 Q2 -- -- $0.39 -- --
04/26/2018 Q1 -- -- $0.37 -- --
02/09/2018 Q4 -- -- $0.31 -- --
10/27/2017 Q3 -- -- $0.22 -- --
07/28/2017 Q2 -- -- $0.30 -- --
04/27/2017 Q1 -- -- $0.19 -- --
02/03/2017 Q4 -- -- $0.19 -- --
10/28/2016 Q3 -- -- $0.27 -- --
07/29/2016 Q2 -- -- $0.25 -- --
04/28/2016 Q1 -- -- $0.24 -- --
02/05/2016 Q4 -- -- $0.21 -- --
10/23/2015 Q3 -- -- $0.22 -- --
07/24/2015 Q2 -- -- $0.25 -- --
04/23/2015 Q1 -- -- $0.28 -- --

Gorman-Rupp Earnings Questions

  • How Much did Gorman-Rupp Generate in Revenue Last Quarter?

    Gorman-Rupp reported $162.7M worth of top line sales in its most recent quarter.

  • Did Gorman-Rupp Beat Earnings Last Quarter?

    Gorman-Rupp announced earnings per share of $0.42 which represents a miss of analyst forecast a $0.45 per share.

  • Is Gorman-Rupp Profitable?

    Gorman-Rupp reported $49.2M that represents $1.88 per share over the last quarter.

  • What is the Analyst Consensus for Gorman-Rupp EPS Next Year?

    Gorman-Rupp's earnings are forecast to grow from $1.53 per share to $1.78 per share next year representing an increase of 29.41%.

  • When is Gorman-Rupp's Earnings Date?

    Gorman-Rupp's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock